Ziv Aviram - Twist Bioscience President CEO, Co-Founder, Executive Director

0ME Stock  EUR 31.20  0.12  0.38%   

CEO

Mr. Ziv Aviram is President, Chief Executive Officer, CoFounder, Executive Director of Mobileye NV. Prior to Mobileye, Mr. Aviram was the CEO of three Israeli companies, all leaders in their fields, . Mr. Aviram has, in all three cases, taken the companies from loss to profit by restructuring the organization appropriately. Since 2010 Mr. Aviram is also cofounder, President and Chief Executive Officer of OrCam.
Age 56
Phone800 719 0671
Webhttps://www.twistbioscience.com

Twist Bioscience Management Efficiency

The company has return on total asset (ROA) of (0.175) % which means that it has lost $0.175 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.312) %, meaning that it generated substantial loss on money invested by shareholders. Twist Bioscience's management efficiency ratios could be used to measure how well Twist Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 63.76 M in total debt with debt to equity ratio (D/E) of 0.1, which may suggest the company is not taking enough advantage from borrowing. Twist Bioscience Corp has a current ratio of 10.31, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Twist Bioscience until it has trouble settling it off, either with new capital or with free cash flow. So, Twist Bioscience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Twist Bioscience Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Twist to invest in growth at high rates of return. When we think about Twist Bioscience's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CEO Age

William WaySouthwest Airlines Co
60
Dimitrios GerogiannisAegean Airlines SA
N/A
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Twist Bioscience Corporation was founded in 2013 and is headquartered in South San Francisco, California. TWIST BIOSCIENCEDL operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 525 people. Twist Bioscience Corp (0ME) is traded on Frankfurt Exchange in Germany and employs 989 people.

Management Performance

Twist Bioscience Corp Leadership Team

Elected by the shareholders, the Twist Bioscience's board of directors comprises two types of representatives: Twist Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Twist. The board's role is to monitor Twist Bioscience's management team and ensure that shareholders' interests are well served. Twist Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Twist Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yonah Lloyd, Chief Communications Officer and Senior Vice President - Business Development
Gaby Hayon, Senior Vice President - Research & Development
Bill Peck, Chief Technology Officer
Pini Segal, Vice President - Finance & Human Resources
William Banyai, Senior Vice President of Research and Development, General Manager of Data Storage and Director
Eyal Desheh, Non-Executive Independent Director
Daniel Galves, Chief Communications Officer and Senior Vice-President
Robert Ragusa, Independent Director
Elad Serfaty, Vice President and General Manager of Aftermarket Division
Tal Babaioff, Vice President - Automotive Projects
Liz Yerushalmi, Vice President Legal Affairs
Eli Barkat, Non-Executive Independent Director
Patrick Weiss, Senior Vice President - Research & Development, General Manager - Data storage
Shai ShalevShwartz, Vice President - Technology
Martin Kunz, Senior Vice President - Operation
Judith Richter, Non-Executive Independent Director
Aaron Sato, Chief Scientific Officer, Biopharma and Vice President Protein Engineering
Shotaro Kawahara, CEO, Mobileye Japan Ltd
Jan Johannessen, Independent Director
Erin Smith, Senior Vice President - Government affairs and Public policy
Mark Daniels, Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer and Secretary
Itay Gat, Senior Vice President of Production Programs
Angela Bitting, Senior Vice President - Corporate Affairs
Elchanan Rushinek, Senior Vice President - Engineering
Ofer Maharshak, CFO, Senior Vice President
Gideon Stein, Chief Research Scientist
Keith Crandell, Independent Director
Robert Chess, Lead Independent Director
Frederick Craves, Independent Director
Yoram Gdalyahu, Vice President of Algorithms development
Emily Leproust, Chairman of the Board, President, Chief Executive Officer
Erez Dagan, Vice President of Advanced technology
Peter Neustadter, Non-Executive Independent Director and Presiding Director
Tomaso Poggio, Non-Executive Independent Director
Patrick Finn, Senior Vice President - Commercial operations
Nelson Chan, Independent Director
Kevin Yankton, VP Officer
Amnon Shashua, Chairman of the Board, Co-Founder, CTO, Executive Director
Ziv Aviram, President CEO, Co-Founder, Executive Director
Siyuan Chen, Chief Technology Officer
Dennis Cho, Gen VP
David Yoffie, Strategic Advisor
James Thorburn, Chief Financial Officer
Xiaoying Mai, Independent Director
Nicolas Barthelemy, Independent Director
Paula Green, Senior Vice President of Human Resources

Twist Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Twist Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Twist Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Twist Bioscience's short interest history, or implied volatility extrapolated from Twist Bioscience options trading.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
When determining whether Twist Bioscience Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Twist Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Twist Bioscience Corp Stock. Highlighted below are key reports to facilitate an investment decision about Twist Bioscience Corp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Twist Stock analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Please note, there is a significant difference between Twist Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Twist Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Twist Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.